Tag Archives: gild

IBD 50’s 5 Top Drug Stocks: Active In R&D And M&A

Top-rated drugmakers such as Valeant Pharmaceuticals International (VRX) and Celgene (CELG) have been busy in the lab and on Wall Street, taking part in big merger deals. Today’s IBD 50 list features five top-rated drugmakers. In addition to Valeant and Celgene, the list includes Regeneron Pharmaceuticals (REGN), Lannett (LCI) and Allergan (AGN). On Friday Biogen Idec (BIIB) priced $6 billion of senior notes, a day after Gilead Sciences (GILD)

Gilead Leads 4 Drugmakers In Top Sector Performers

Following a three-day plummet, stocks popped Tuesday, with several top drugmakers like Gilead making a climb. Today’s Screen of the Day focuses on Top Sector Performers. Over half of a stock’s price move can be attributed to the strength of its industry subgroup and sector. Biotech Gilead Sciences (GILD) develops treatments for HIV/AIDS, liver diseases, heart disease and other life-threatening illnesses. Gilead’s blockbuster hepatitis C

These Four Pharmaceuticals Are Top Sector Performers

Following a three-day plummet, stocks popped at the open, with several top drugmakers making a climb. Today’s Screen of the Day focuses on Top Sector Performers. Over half of a stock’s price move can be attributed to the strength of its industry subgroup and sector. Biotech Gilead Sciences (GILD) develops treatments for HIV/AIDS, liver diseases, heart disease and other life-threatening illnesses. Its blockbuster hepatitis C treatments, Sovaldi and